Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies.

导出 LinkOut

翻译打印收藏纠错

第一作者： FanJun,Meng

第一单位： Department of Radiation Oncology, Jieyang People's Hospital (Jieyang Affiliated Hospital, Sun Yat-sen University), Jieyang, China.

作者： FanJun,Meng ^[1] ; XinLei,Ai ^[2] ; Bin,Wang ^[3] ; Yin,Zhou ^[4] ; Su,Li ^[2] ; DaQuan,Wang ^[3] ; FangJie,Liu ^[4] ; NaiBin,Chen ^[5] ; Rui,Zhou ^[3] ; JinYu,Guo ^[4] ; XiaoYan,Huang ^[6] ; ShaoHan,Yin ^[2] ; Bo,Qiu ^[3] ; Hui,Liu ^[4]

作者单位： Department of Radiation Oncology, Jieyang People's Hospital (Jieyang Affiliated Hospital, Sun Yat-sen University), Jieyang, China. ^[1] Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[2] State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[3] Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[4] Evidance Medical Technologies Inc., Suzhou, China. ^[5] Department of Clinical Research, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[6] Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[7]

关键词 LQRGC/TCP model concurrent chemoradiotherapy hypo-fractionated radiotherapy in-field locoregional progression-free survival mediastinal malignancy

DOI 10.3389/fonc.2022.974394

PMID 36276120

发布时间 2022-10-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Frontiers in oncology

2022年12卷

974394页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除